vs
null（GPRO）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
null的季度营收约是REPLIGEN CORP的1.0倍（$201.7M vs $197.9M），REPLIGEN CORP同比增速更快（13.6% vs 0.4%），REPLIGEN CORP自由现金流更多（$17.6M vs $15.0M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 13.9%）
GoPro, Inc.是2002年由尼克·伍德曼创立的美国科技企业，最初注册名为伍德曼实验室，总部坐落于加利福尼亚州圣马特奥。该公司主营运动相机生产制造，同时还自主开发配套移动端应用与视频编辑软件。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
GPRO vs RGEN — 直观对比
营收规模更大
GPRO
是对方的1.0倍
$197.9M
营收增速更快
RGEN
高出13.3%
0.4%
自由现金流更多
RGEN
多$2.6M
$15.0M
两年增速更快
RGEN
近两年复合增速
13.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $201.7M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | 31.8% | 52.5% |
| 营业利润率 | -4.1% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 0.4% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $-0.06 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GPRORGEN
| Q4 25 | $201.7M | $197.9M | ||
| Q3 25 | $162.9M | $188.8M | ||
| Q2 25 | $152.6M | $182.4M | ||
| Q1 25 | $134.3M | $169.2M | ||
| Q4 24 | $200.9M | $174.1M | ||
| Q3 24 | $258.9M | $154.9M | ||
| Q2 24 | $186.2M | $154.1M | ||
| Q1 24 | $155.5M | $151.3M |
净利润GPRORGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $-21.3M | $14.9M | ||
| Q2 25 | $-16.4M | $14.9M | ||
| Q1 25 | $-46.7M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $-8.2M | $-654.0K | ||
| Q2 24 | $-47.8M | $3.3M | ||
| Q1 24 | $-339.1M | $2.1M |
毛利率GPRORGEN
| Q4 25 | 31.8% | 52.5% | ||
| Q3 25 | 35.1% | 53.2% | ||
| Q2 25 | 35.8% | 50.0% | ||
| Q1 25 | 32.1% | 53.6% | ||
| Q4 24 | 34.7% | 26.1% | ||
| Q3 24 | 35.5% | 50.0% | ||
| Q2 24 | 30.5% | 49.8% | ||
| Q1 24 | 34.1% | 49.5% |
营业利润率GPRORGEN
| Q4 25 | -4.1% | 9.0% | ||
| Q3 25 | -9.8% | 8.9% | ||
| Q2 25 | -9.2% | 7.6% | ||
| Q1 25 | -33.7% | 3.9% | ||
| Q4 24 | -19.5% | -17.7% | ||
| Q3 24 | -3.1% | -5.1% | ||
| Q2 24 | -25.0% | 1.0% | ||
| Q1 24 | -26.6% | 1.3% |
净利率GPRORGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | -13.0% | 7.9% | ||
| Q2 25 | -10.8% | 8.2% | ||
| Q1 25 | -34.8% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | -3.2% | -0.4% | ||
| Q2 24 | -25.7% | 2.2% | ||
| Q1 24 | -218.1% | 1.4% |
每股收益（稀释后）GPRORGEN
| Q4 25 | $-0.06 | $0.24 | ||
| Q3 25 | $-0.13 | $0.26 | ||
| Q2 25 | $-0.10 | $0.26 | ||
| Q1 25 | $-0.30 | $0.10 | ||
| Q4 24 | $-0.22 | $-0.55 | ||
| Q3 24 | $-0.05 | $-0.01 | ||
| Q2 24 | $-0.31 | $0.06 | ||
| Q1 24 | $-2.24 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $49.7M | $767.6M |
| 总债务越低越好 | $44.3M | $542.2M |
| 股东权益账面价值 | $76.5M | $2.1B |
| 总资产 | $428.0M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.58× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资GPRORGEN
| Q4 25 | $49.7M | $767.6M | ||
| Q3 25 | $152.8M | $748.7M | ||
| Q2 25 | $58.6M | $708.9M | ||
| Q1 25 | $69.6M | $697.2M | ||
| Q4 24 | $102.8M | $757.4M | ||
| Q3 24 | $130.2M | $784.0M | ||
| Q2 24 | $133.0M | $809.1M | ||
| Q1 24 | $133.7M | $780.6M |
总债务GPRORGEN
| Q4 25 | $44.3M | $542.2M | ||
| Q3 25 | $43.9M | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | $525.6M | ||
| Q3 24 | $93.1M | — | ||
| Q2 24 | $92.9M | — | ||
| Q1 24 | $92.7M | — |
股东权益GPRORGEN
| Q4 25 | $76.5M | $2.1B | ||
| Q3 25 | $80.5M | $2.1B | ||
| Q2 25 | $97.9M | $2.1B | ||
| Q1 25 | $110.0M | $2.0B | ||
| Q4 24 | $151.7M | $2.0B | ||
| Q3 24 | $183.9M | $2.0B | ||
| Q2 24 | $184.7M | $2.0B | ||
| Q1 24 | $224.9M | $2.0B |
总资产GPRORGEN
| Q4 25 | $428.0M | $2.9B | ||
| Q3 25 | $538.6M | $2.9B | ||
| Q2 25 | $439.0M | $2.9B | ||
| Q1 25 | $462.5M | $2.9B | ||
| Q4 24 | $543.7M | $2.8B | ||
| Q3 24 | $661.6M | $2.8B | ||
| Q2 24 | $556.8M | $2.9B | ||
| Q1 24 | $575.8M | $2.8B |
负债/权益比GPRORGEN
| Q4 25 | 0.58× | 0.26× | ||
| Q3 25 | 0.55× | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | 0.27× | ||
| Q3 24 | 0.51× | — | ||
| Q2 24 | 0.50× | — | ||
| Q1 24 | 0.41× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $15.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 7.4% | 8.9% |
| 资本支出强度资本支出/营收 | 0.3% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-24.0M | $93.9M |
8季度趋势，按日历期对齐
经营现金流GPRORGEN
| Q4 25 | $15.6M | $25.7M | ||
| Q3 25 | $12.2M | $48.1M | ||
| Q2 25 | $8.8M | $28.6M | ||
| Q1 25 | $-57.2M | $15.0M | ||
| Q4 24 | $-25.1M | $39.2M | ||
| Q3 24 | $-2.2M | $49.3M | ||
| Q2 24 | $605.0K | $42.2M | ||
| Q1 24 | $-98.4M | $44.7M |
自由现金流GPRORGEN
| Q4 25 | $15.0M | $17.6M | ||
| Q3 25 | $11.2M | $43.4M | ||
| Q2 25 | $8.3M | $21.5M | ||
| Q1 25 | $-58.5M | $11.4M | ||
| Q4 24 | $-25.5M | $33.6M | ||
| Q3 24 | $-4.2M | $42.3M | ||
| Q2 24 | $-111.0K | $37.4M | ||
| Q1 24 | $-99.4M | $36.4M |
自由现金流率GPRORGEN
| Q4 25 | 7.4% | 8.9% | ||
| Q3 25 | 6.9% | 23.0% | ||
| Q2 25 | 5.4% | 11.8% | ||
| Q1 25 | -43.5% | 6.8% | ||
| Q4 24 | -12.7% | 19.3% | ||
| Q3 24 | -1.6% | 27.3% | ||
| Q2 24 | -0.1% | 24.3% | ||
| Q1 24 | -63.9% | 24.0% |
资本支出强度GPRORGEN
| Q4 25 | 0.3% | 4.1% | ||
| Q3 25 | 0.6% | 2.5% | ||
| Q2 25 | 0.3% | 3.9% | ||
| Q1 25 | 1.0% | 2.1% | ||
| Q4 24 | 0.2% | 3.2% | ||
| Q3 24 | 0.8% | 4.5% | ||
| Q2 24 | 0.4% | 3.1% | ||
| Q1 24 | 0.6% | 5.5% |
现金转化率GPRORGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GPRO
| Subscription And Services | $106.3M | 53% |
| Other | $95.4M | 47% |
RGEN
暂无分部数据
